X4 Pharmaceuticals, Inc reports

Company location: Boston, MA
Fiscal year end: 31 December

X4 Pharmaceuticals, Inc has filed 800 SEC EDGAR filings since 24 Sep 2010

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 351-375 of 800 matching filings.

Per page

25

Current page

15

4

FORM 4

Filing date: 27 Jun 2022
Reporting date: 06 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Jun 2022
Reporting date: 06 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Jun 2022
Reporting date: 06 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Jun 2022
Reporting date: 06 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Jun 2022
Reporting date: 06 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Jun 2022
Reporting date: 24 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Jun 2022
Reporting date: 06 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Jun 2022
Reporting date: 24 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Jun 2022
Reporting date: 24 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 27 Jun 2022
Reporting date: 24 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 Jun 2022
Reporting date: 16 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 Jun 2022
Reporting date: 16 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 Jun 2022
Reporting date: 16 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 Jun 2022
Reporting date: 16 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38295

8-K

Filing date: 07 Jun 2022
Reporting date: 06 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 06 Jun 2022
Reporting date: 03 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38295

8-K

Filing date: 20 May 2022
Reporting date: 20 May 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

EFFECT File 333-264459

EFFECT filing

Filing date: 13 May 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-38295

10-Q

Filing date: 12 May 2022
Reporting date: 31 Mar 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 12 May 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38295

8-K

Filing date: 12 May 2022
Reporting date: 12 May 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

UPLOAD

UPLOAD filing

Filing date: 28 Apr 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEFA14A File 001-38295

DEFA14A

Filing date: 25 Apr 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-38295

DEF 14A

Filing date: 25 Apr 2022
Reporting date: 06 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

S-3 File 333-264459

S-3

Filing date: 22 Apr 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .